ALKS vs UTHR · P/E 14, rev $1.56B vs P/E 20, rev $2.88B
Alkermes Plc (ALKS) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the ALKS and UTHR stock pages for the full models.
Not investment advice.